543963 — Shelter Pharma Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for Shelter Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Interim Report	ARS	PRESS
Standards:	IAS	IAS	—	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	225	301	362	400	507
Cost of Revenue
Gross Profit	13.4	42.1	99	111	136
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	224	272	292	317	409
Operating Profit	0.574	28.1	69.9	83.4	98
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	0.627	28.1	69.8	82.8	96.8
Provision for Income Taxes
Net Income After Taxes	0.413	20.6	52.1	62	72.4
Net Income Before Extraordinary Items
Net Income	0.413	20.6	52.1	62	72.4
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	0.412	20.6	52.1	62	72.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.036	1.78	5.08	5.36	6.26
Dividends per Share